Zhonghan Shengtai

Zhonghan Shengtai Biotechnology Co., Ltd. was established in December 2010, with a total investment of 300 million yuan and a total floor area of 38,000 square meters. It is a high-tech biopharmaceutical enterprise mainly engaged in the entire industrial chain of in-vitro diagnostic products, covering the development of raw materials for in-vitro diagnostics, research and development, production, sales and service of diagnostic instruments and reagents, and technology incubation, third-party molecular diagnosis testing and bioinformatics technology services, third-party cold-chain logistics of medical devices, and other fields.

The company possesses a complete set of R&D and production equipment and cleanrooms for in-vitro diagnostic instruments, reagents and raw materials in POCT, clinical chemistry, immunology and molecular diagnostics, with an annual production capacity of 40 million diagnostic kits per single shift; it has built a 25,000-square-meter in-vitro diagnostic reagent production base and a 1,700-square-meter public laboratory platform; it has established long-term and stable business relationships with dozens of domestic and foreign manufacturers, has built a sound marketing channel, and its products are sold in 30 provinces, municipalities and autonomous regions across the country, with nearly 7,000 customers.

Zhonghan Shengtai is a key industrial investment project of Hangzhou in 2011, a undertaking unit of the National Science and Technology Support Program during the "Twelfth Five-Year Plan" period, and a undertaking unit of major research and development projects of Zhejiang Province; it has built a Zhejiang Provincial Postdoctoral Workstation, a Zhejiang Provincial Science and Technology Business Incubator, a Zhejiang Provincial Demonstration Park for Entrepreneurship and Innovation of Small and Micro Enterprises, the Zhonghan Shengtai-Shanghai Jiao Tong University Joint Laboratory of Medical Diagnostic Technology, and the Zhejiang Provincial Centralized Supervision Platform for Entry and Exit of Special Articles. As a unit member of the National Technical Committee for Standardization of Medical Clinical Laboratory and In-vitro Diagnostic Systems (SAC/TC136), Zhonghan Shengtai has participated in the formulation and drafting of a number of national industry standards.

With the mission of "Focusing on medical diagnosis, serving human health", the company, through joint efforts with partners and strong support from all sectors of society, continues to innovate and make breakthroughs in technology platforms and internationalization, create more value for customers, and make more contributions to rewarding shareholders and society.